SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (830)11/23/2001 11:24:41 AM
From: Larry Liebman  Respond to of 1834
 
No complaints here. After our cyclical nuclear winter in biotechs (though we unfortunately had company from our technology brethren this rotation), it is comforting to see the likes of NBIX, IMCL, CVTX, and CELG demonstrate compassion for their investors! I am surprised that some bio's, i.e., MEDX, haven't bounced higher.



To: scaram(o)uche who wrote (830)11/23/2001 5:15:07 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 1834
 
<<10 down, 10 to go. >.

10 + 10, or 10 by 10?

:)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News